EUVD-2025-16679Vulnerability Assessment
| Weakness |
CWE
OWASP Top 10:2025
A06:2021 - Vulnerable and Outdated Components
ASVS 5.0
V15 - Secure Coding and Architecture Hardware security identifier management
|
| Impact | Exposed information (credentials, internal paths, user data, configuration) can be leveraged for further attacks or regulatory violations. With a CVSS score of 6.5 (MEDIUM), this represents a moderate risk. |
| Exploit ScenarioDerived | An attacker triggers error conditions or accesses improperly protected endpoints to extract sensitive internal information from the application. |
Get an e-mail when this CVE is exploited, patched or re-scored. Free account.
Alert meAnalysisAIv1 – Mar 14, 2026
Clinical Collaboration Platform 12.2.1.5 has a weak logout system where the session token remains valid after logout and allows a remote attacker to obtain sensitive information and execute arbitrary code.
Earlier versions of this analysis (1)
RemediationAI
Implement proper access controls. Sanitize error messages in production. Review logging practices to avoid capturing sensitive data.
Affected VersionsENISA
Affects your stack
Find out whether the stacks and servers you run are on an affected version.
Checking this CVE against your own stacks and servers is part of the Basic plan and up.
Technical ContextAI · show details
Information disclosure occurs when an application inadvertently reveals sensitive data to unauthorized actors through error messages, logs, or improper access controls.
Know when Clinical Collaboration Platform gets its next vulnerability
- Watch products and get an email when something new is published
- Check this CVE against your own stack and servers
- Exploit and PoC references, threat intelligence from 22 sources
No credit card · 7-day full trial
Severity by source
AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Primary rating from NVD · only source for this CVE.
CVSS VectorNVD
Executive ViewAI
Organizations using Clinical Collaboration Platform 12.2.1.5 should be aware of notable risk from CVE-2025-27955 rated CVSS 6.5. Exploitation could compromise the security of affected deployments. Organizations should apply vendor updates when available and monitor for exploitation.
Apply vendor patch. If patching is delayed: restrict network access and enable monitoring.
Threat Intelligence Overview
NVD
CVE.org
EPSS
GitHub
How this decision was reached
The engine reads each signal below and applies a fixed list of rules from top to bottom. The first rule that matches sets the recommended action – like a statement, every line is shown.
What every action level means
SSVC AssessmentENISA
Priority Score
Attack Technique
Remote Code Execution represents the critical moment when an attacker successfully runs arbitrary code on a target system without physical access.
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, prov
An issue in Clinical Collaboration Platform 12.2.1.5 allows a remote attacker to obtain sensitive information and execut
An issue in Clinical Collaboration Platform 12.2.1.5 allows a remote attacker to obtain sensitive information and execut
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not properly control the allocation and mainten
When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, do
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior. Rated medium severity (CVSS 4.3), this vulnerability
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-
Exploit-DB